, /PRNewswire/ -- The global pneumonia testing market size is estimated to grow by from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.69% during the forecast period.
Rising prevalence of pneumonia and concerns associated with pneumonia mortality is driving market growth, with a trend towards growing importance of promotional activities. However, poor healthcare infrastructure in developing economies poses a challenge. Key market players include Abbott Laboratories, Acumen Diagnostics Pte Ltd.
, and Co., bioMerieux SA, Bio Rad Laboratories Inc., Danaher Corp.
, Diamedica SIA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc.
, Laboratory Corp. Of America Holdings, LGC Science Group Holdings Ltd., Meridian Bioscience Inc.
, OpGen Inc., Pfizer Inc., Quest Diagnostics Inc.
, Quidelortho Corp., Siemens AG, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.
Get a detailed analysis on regions, market segments, customer landscape, and companies- The diagnostic market for pneumonia tests faces unique challenges due to the specialized nature of the products and limited end-user awareness. Vendors focus on expanding distribution networks and increasing product availability. Thermo Fisher Scientific and Bio-Rad Laboratories utilize YouTube channels for product explanation, reaching 140.
84 million and 1.2 million subscribers, respectively. Non-profit organizations conduct workshops to enhance awareness.
Market growth is anticipated as vendors recogn.
